Metraipolis › archive › dc_c99dd036dba0

Ligand-based pharmacophore modeling for the discovery of NaV1.7 inhibitors — Europe PMC PMID:42563012

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42563012
DOI
10.1007/s10822-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-10-08T07:28:54.737Z
SHA-256 of the archived text
e2e27d3b238bc381c3d10ba4666d3023178cdece22529a2a1dad9c57e75f3bf6
Stable URL of this page
https://metraipolis.com/documento/dc_c99dd036dba0

How to cite

Ligand-based pharmacophore modeling for the discovery of NaV1.7 inhibitors — Europe PMC PMID:42563012 — Europe PMC (en), https://europepmc.org/article/MED/42563012 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c99dd036dba0 (Metraipolis archive dc_c99dd036dba0, sha256 e2e27d3b238bc381c3d10ba4666d3023178cdece22529a2a1dad9c57e75f3bf6)
BibTeX
@misc{dcc99dd036dba0,
  title = {Ligand-based pharmacophore modeling for the discovery of NaV1.7 inhibitors — Europe PMC PMID:42563012},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42563012},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c99dd036dba0; sha256 e2e27d3b238bc381c3d10ba4666d3023178cdece22529a2a1dad9c57e75f3bf6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42563012. Agents can read the archived copy with the MCP tool read_document.